Cargando…
Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies
Epilepsy is the most common chronic neurologic disorder in the world, affecting 1-2% of the population. Besides, 30% of epilepsy patients are drug-resistant. Genomic mutations seem to play a key role in its etiology and knowledge of strong effect mutations in protein structures might improve predict...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686309/ https://www.ncbi.nlm.nih.gov/pubmed/32933463 http://dx.doi.org/10.2174/1570159X18666200915151909 |